Activation of human basophils through the IL-8 receptor

IL-8 and its structural analogs derived from blood platelets have been proposed as stimuli of IgE-independent basophil activation. In order to clarify the mechanism of action of these peptides, we examined the effects of pure IL-8, connective tissue-activating peptide III (CTAP-III), neutrophil-acti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of immunology (1950) 1992-10, Vol.149 (8), p.2662-2667
Hauptverfasser: Krieger, M, Brunner, T, Bischoff, SC, von Tscharner, V, Walz, A, Moser, B, Baggiolini, M, Dahinden, CA
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2667
container_issue 8
container_start_page 2662
container_title The Journal of immunology (1950)
container_volume 149
creator Krieger, M
Brunner, T
Bischoff, SC
von Tscharner, V
Walz, A
Moser, B
Baggiolini, M
Dahinden, CA
description IL-8 and its structural analogs derived from blood platelets have been proposed as stimuli of IgE-independent basophil activation. In order to clarify the mechanism of action of these peptides, we examined the effects of pure IL-8, connective tissue-activating peptide III (CTAP-III), neutrophil-activating peptide 2 (NAP-2), and platelet factor 4 (PF-4) on blood basophils with and without pretreatment by IL-3, which modulates mediator release. After pretreatment with IL-3, significant histamine release was observed with 10(-8) M and 10(-7) M IL-8 and 10(-7) M NAP-2, but not with the other peptides. At higher concentrations (10(-6) M), however, all IL-8 analogs, as well as the unrelated cationic peptides poly-D-lysine, histone VS, and lysozyme, induced histamine release to variable degrees. Binding and competition studies with [125I]IL-8 revealed specific IL-8R on basophils from a patient with chronic myelogenous leukemia and normal individuals. From 3500 to 9600 receptors with a mean Kd value of 0.15 nM were found on average per chronic myelogenous leukemia and normal basophil, respectively. NAP-2 weakly competed for IL-8 binding. IL-8 and, to a lesser extent, NAP-2 led to a transient rise of cytosolic free calcium concentration ([Ca2+]i), which was independent of a preexposure to IL-3. IL-8 prevented the [Ca2+]i rise induced by NAP-2, but did not influence [Ca2+]i responses to other agonists, e.g. C5a, C3a, or platelet-activating factor. IL-8 induced [Ca2+]i changes and histamine release in IL-3-primed basophils were pertussis toxin sensitive. CTAP-III or PF-4 did not compete for IL-8 binding, did not induce [Ca2+]i changes, and did not influence the [Ca2+]i response to IL-8 and NAP-2. This study shows that IL-8 and NAP-2 activate human basophils by a receptor-mediated mechanism similar to that operating in neutrophils. At high concentrations histamine release can also be induced by cationic peptides by a mechanism that does not involve the IL-8R, and probably depends on cationic interactions.
doi_str_mv 10.4049/jimmunol.149.8.2662
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73237119</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73237119</sourcerecordid><originalsourceid>FETCH-LOGICAL-c437t-d4d665d5f525cba1dd44d2928e10f2dfd964a2e04fb4b1c4fd4147b22eda1873</originalsourceid><addsrcrecordid>eNqFkEtr3DAUhUVpSKZJfkEJeFHalSe60rVkL8PQR2Cgm-yFrEesYFsTye7Qfx8PM0m66-os7nfPgY-Qz0DXSLG5fQrDMI-xXwM263rNhGAfyAqqipZCUPGRrChlrAQp5AX5lPMTpVRQhufkHHjNOYMVkXdmCn_0FOJYRF9086DHotU57rrQ52LqUpwfuyVdcb8t6yI543ZTTFfkzOs-u-tTXpKHH98fNr_K7e-f95u7bWmQy6m0aIWobOUrVplWg7WIljWsdkA9s942AjVzFH2LLRj0FgFly5izGmrJL8nXY-0uxefZ5UkNIRvX93p0cc5KcsYlQPNfEAQH5AwXkB9Bk2LOyXm1S2HQ6a8Cqg5a1atWtWhVtTpoXb5uTvVzOzj7_nP0uNy_nO46G937pEcT8huGiJI3h_FvR6wLj90-JKfyoPt-KQW13-__GXwB6zSPFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16314324</pqid></control><display><type>article</type><title>Activation of human basophils through the IL-8 receptor</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Krieger, M ; Brunner, T ; Bischoff, SC ; von Tscharner, V ; Walz, A ; Moser, B ; Baggiolini, M ; Dahinden, CA</creator><creatorcontrib>Krieger, M ; Brunner, T ; Bischoff, SC ; von Tscharner, V ; Walz, A ; Moser, B ; Baggiolini, M ; Dahinden, CA</creatorcontrib><description>IL-8 and its structural analogs derived from blood platelets have been proposed as stimuli of IgE-independent basophil activation. In order to clarify the mechanism of action of these peptides, we examined the effects of pure IL-8, connective tissue-activating peptide III (CTAP-III), neutrophil-activating peptide 2 (NAP-2), and platelet factor 4 (PF-4) on blood basophils with and without pretreatment by IL-3, which modulates mediator release. After pretreatment with IL-3, significant histamine release was observed with 10(-8) M and 10(-7) M IL-8 and 10(-7) M NAP-2, but not with the other peptides. At higher concentrations (10(-6) M), however, all IL-8 analogs, as well as the unrelated cationic peptides poly-D-lysine, histone VS, and lysozyme, induced histamine release to variable degrees. Binding and competition studies with [125I]IL-8 revealed specific IL-8R on basophils from a patient with chronic myelogenous leukemia and normal individuals. From 3500 to 9600 receptors with a mean Kd value of 0.15 nM were found on average per chronic myelogenous leukemia and normal basophil, respectively. NAP-2 weakly competed for IL-8 binding. IL-8 and, to a lesser extent, NAP-2 led to a transient rise of cytosolic free calcium concentration ([Ca2+]i), which was independent of a preexposure to IL-3. IL-8 prevented the [Ca2+]i rise induced by NAP-2, but did not influence [Ca2+]i responses to other agonists, e.g. C5a, C3a, or platelet-activating factor. IL-8 induced [Ca2+]i changes and histamine release in IL-3-primed basophils were pertussis toxin sensitive. CTAP-III or PF-4 did not compete for IL-8 binding, did not induce [Ca2+]i changes, and did not influence the [Ca2+]i response to IL-8 and NAP-2. This study shows that IL-8 and NAP-2 activate human basophils by a receptor-mediated mechanism similar to that operating in neutrophils. At high concentrations histamine release can also be induced by cationic peptides by a mechanism that does not involve the IL-8R, and probably depends on cationic interactions.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.149.8.2662</identifier><identifier>PMID: 1383321</identifier><identifier>CODEN: JOIMA3</identifier><language>eng</language><publisher>Bethesda, MD: Am Assoc Immnol</publisher><subject>Amino Acid Sequence ; Basophils - drug effects ; Basophils - physiology ; beta-Thromboglobulin ; Binding, Competitive ; Biological and medical sciences ; Blood Coagulation Factors - pharmacology ; Calcium - metabolism ; Cells, Cultured ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Histamine Release - drug effects ; Humans ; Immunobiology ; Interleukin-3 - pharmacology ; Interleukin-8 - metabolism ; Interleukin-8 - pharmacology ; Molecular Sequence Data ; Myeloid cells: ontogeny, maturation, markers, receptors ; Peptides - pharmacology ; Pertussis Toxin ; Platelet Factor 4 - pharmacology ; Polynuclears ; Receptors, Immunologic - drug effects ; Receptors, Interleukin-8A ; Virulence Factors, Bordetella - pharmacology</subject><ispartof>The Journal of immunology (1950), 1992-10, Vol.149 (8), p.2662-2667</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c437t-d4d665d5f525cba1dd44d2928e10f2dfd964a2e04fb4b1c4fd4147b22eda1873</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4447394$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1383321$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krieger, M</creatorcontrib><creatorcontrib>Brunner, T</creatorcontrib><creatorcontrib>Bischoff, SC</creatorcontrib><creatorcontrib>von Tscharner, V</creatorcontrib><creatorcontrib>Walz, A</creatorcontrib><creatorcontrib>Moser, B</creatorcontrib><creatorcontrib>Baggiolini, M</creatorcontrib><creatorcontrib>Dahinden, CA</creatorcontrib><title>Activation of human basophils through the IL-8 receptor</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>IL-8 and its structural analogs derived from blood platelets have been proposed as stimuli of IgE-independent basophil activation. In order to clarify the mechanism of action of these peptides, we examined the effects of pure IL-8, connective tissue-activating peptide III (CTAP-III), neutrophil-activating peptide 2 (NAP-2), and platelet factor 4 (PF-4) on blood basophils with and without pretreatment by IL-3, which modulates mediator release. After pretreatment with IL-3, significant histamine release was observed with 10(-8) M and 10(-7) M IL-8 and 10(-7) M NAP-2, but not with the other peptides. At higher concentrations (10(-6) M), however, all IL-8 analogs, as well as the unrelated cationic peptides poly-D-lysine, histone VS, and lysozyme, induced histamine release to variable degrees. Binding and competition studies with [125I]IL-8 revealed specific IL-8R on basophils from a patient with chronic myelogenous leukemia and normal individuals. From 3500 to 9600 receptors with a mean Kd value of 0.15 nM were found on average per chronic myelogenous leukemia and normal basophil, respectively. NAP-2 weakly competed for IL-8 binding. IL-8 and, to a lesser extent, NAP-2 led to a transient rise of cytosolic free calcium concentration ([Ca2+]i), which was independent of a preexposure to IL-3. IL-8 prevented the [Ca2+]i rise induced by NAP-2, but did not influence [Ca2+]i responses to other agonists, e.g. C5a, C3a, or platelet-activating factor. IL-8 induced [Ca2+]i changes and histamine release in IL-3-primed basophils were pertussis toxin sensitive. CTAP-III or PF-4 did not compete for IL-8 binding, did not induce [Ca2+]i changes, and did not influence the [Ca2+]i response to IL-8 and NAP-2. This study shows that IL-8 and NAP-2 activate human basophils by a receptor-mediated mechanism similar to that operating in neutrophils. At high concentrations histamine release can also be induced by cationic peptides by a mechanism that does not involve the IL-8R, and probably depends on cationic interactions.</description><subject>Amino Acid Sequence</subject><subject>Basophils - drug effects</subject><subject>Basophils - physiology</subject><subject>beta-Thromboglobulin</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Blood Coagulation Factors - pharmacology</subject><subject>Calcium - metabolism</subject><subject>Cells, Cultured</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Histamine Release - drug effects</subject><subject>Humans</subject><subject>Immunobiology</subject><subject>Interleukin-3 - pharmacology</subject><subject>Interleukin-8 - metabolism</subject><subject>Interleukin-8 - pharmacology</subject><subject>Molecular Sequence Data</subject><subject>Myeloid cells: ontogeny, maturation, markers, receptors</subject><subject>Peptides - pharmacology</subject><subject>Pertussis Toxin</subject><subject>Platelet Factor 4 - pharmacology</subject><subject>Polynuclears</subject><subject>Receptors, Immunologic - drug effects</subject><subject>Receptors, Interleukin-8A</subject><subject>Virulence Factors, Bordetella - pharmacology</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtr3DAUhUVpSKZJfkEJeFHalSe60rVkL8PQR2Cgm-yFrEesYFsTye7Qfx8PM0m66-os7nfPgY-Qz0DXSLG5fQrDMI-xXwM263rNhGAfyAqqipZCUPGRrChlrAQp5AX5lPMTpVRQhufkHHjNOYMVkXdmCn_0FOJYRF9086DHotU57rrQ52LqUpwfuyVdcb8t6yI543ZTTFfkzOs-u-tTXpKHH98fNr_K7e-f95u7bWmQy6m0aIWobOUrVplWg7WIljWsdkA9s942AjVzFH2LLRj0FgFly5izGmrJL8nXY-0uxefZ5UkNIRvX93p0cc5KcsYlQPNfEAQH5AwXkB9Bk2LOyXm1S2HQ6a8Cqg5a1atWtWhVtTpoXb5uTvVzOzj7_nP0uNy_nO46G937pEcT8huGiJI3h_FvR6wLj90-JKfyoPt-KQW13-__GXwB6zSPFA</recordid><startdate>19921015</startdate><enddate>19921015</enddate><creator>Krieger, M</creator><creator>Brunner, T</creator><creator>Bischoff, SC</creator><creator>von Tscharner, V</creator><creator>Walz, A</creator><creator>Moser, B</creator><creator>Baggiolini, M</creator><creator>Dahinden, CA</creator><general>Am Assoc Immnol</general><general>American Association of Immunologists</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19921015</creationdate><title>Activation of human basophils through the IL-8 receptor</title><author>Krieger, M ; Brunner, T ; Bischoff, SC ; von Tscharner, V ; Walz, A ; Moser, B ; Baggiolini, M ; Dahinden, CA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c437t-d4d665d5f525cba1dd44d2928e10f2dfd964a2e04fb4b1c4fd4147b22eda1873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Amino Acid Sequence</topic><topic>Basophils - drug effects</topic><topic>Basophils - physiology</topic><topic>beta-Thromboglobulin</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Blood Coagulation Factors - pharmacology</topic><topic>Calcium - metabolism</topic><topic>Cells, Cultured</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Histamine Release - drug effects</topic><topic>Humans</topic><topic>Immunobiology</topic><topic>Interleukin-3 - pharmacology</topic><topic>Interleukin-8 - metabolism</topic><topic>Interleukin-8 - pharmacology</topic><topic>Molecular Sequence Data</topic><topic>Myeloid cells: ontogeny, maturation, markers, receptors</topic><topic>Peptides - pharmacology</topic><topic>Pertussis Toxin</topic><topic>Platelet Factor 4 - pharmacology</topic><topic>Polynuclears</topic><topic>Receptors, Immunologic - drug effects</topic><topic>Receptors, Interleukin-8A</topic><topic>Virulence Factors, Bordetella - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krieger, M</creatorcontrib><creatorcontrib>Brunner, T</creatorcontrib><creatorcontrib>Bischoff, SC</creatorcontrib><creatorcontrib>von Tscharner, V</creatorcontrib><creatorcontrib>Walz, A</creatorcontrib><creatorcontrib>Moser, B</creatorcontrib><creatorcontrib>Baggiolini, M</creatorcontrib><creatorcontrib>Dahinden, CA</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krieger, M</au><au>Brunner, T</au><au>Bischoff, SC</au><au>von Tscharner, V</au><au>Walz, A</au><au>Moser, B</au><au>Baggiolini, M</au><au>Dahinden, CA</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Activation of human basophils through the IL-8 receptor</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>1992-10-15</date><risdate>1992</risdate><volume>149</volume><issue>8</issue><spage>2662</spage><epage>2667</epage><pages>2662-2667</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><coden>JOIMA3</coden><abstract>IL-8 and its structural analogs derived from blood platelets have been proposed as stimuli of IgE-independent basophil activation. In order to clarify the mechanism of action of these peptides, we examined the effects of pure IL-8, connective tissue-activating peptide III (CTAP-III), neutrophil-activating peptide 2 (NAP-2), and platelet factor 4 (PF-4) on blood basophils with and without pretreatment by IL-3, which modulates mediator release. After pretreatment with IL-3, significant histamine release was observed with 10(-8) M and 10(-7) M IL-8 and 10(-7) M NAP-2, but not with the other peptides. At higher concentrations (10(-6) M), however, all IL-8 analogs, as well as the unrelated cationic peptides poly-D-lysine, histone VS, and lysozyme, induced histamine release to variable degrees. Binding and competition studies with [125I]IL-8 revealed specific IL-8R on basophils from a patient with chronic myelogenous leukemia and normal individuals. From 3500 to 9600 receptors with a mean Kd value of 0.15 nM were found on average per chronic myelogenous leukemia and normal basophil, respectively. NAP-2 weakly competed for IL-8 binding. IL-8 and, to a lesser extent, NAP-2 led to a transient rise of cytosolic free calcium concentration ([Ca2+]i), which was independent of a preexposure to IL-3. IL-8 prevented the [Ca2+]i rise induced by NAP-2, but did not influence [Ca2+]i responses to other agonists, e.g. C5a, C3a, or platelet-activating factor. IL-8 induced [Ca2+]i changes and histamine release in IL-3-primed basophils were pertussis toxin sensitive. CTAP-III or PF-4 did not compete for IL-8 binding, did not induce [Ca2+]i changes, and did not influence the [Ca2+]i response to IL-8 and NAP-2. This study shows that IL-8 and NAP-2 activate human basophils by a receptor-mediated mechanism similar to that operating in neutrophils. At high concentrations histamine release can also be induced by cationic peptides by a mechanism that does not involve the IL-8R, and probably depends on cationic interactions.</abstract><cop>Bethesda, MD</cop><pub>Am Assoc Immnol</pub><pmid>1383321</pmid><doi>10.4049/jimmunol.149.8.2662</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof The Journal of immunology (1950), 1992-10, Vol.149 (8), p.2662-2667
issn 0022-1767
1550-6606
language eng
recordid cdi_proquest_miscellaneous_73237119
source MEDLINE; Alma/SFX Local Collection
subjects Amino Acid Sequence
Basophils - drug effects
Basophils - physiology
beta-Thromboglobulin
Binding, Competitive
Biological and medical sciences
Blood Coagulation Factors - pharmacology
Calcium - metabolism
Cells, Cultured
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Histamine Release - drug effects
Humans
Immunobiology
Interleukin-3 - pharmacology
Interleukin-8 - metabolism
Interleukin-8 - pharmacology
Molecular Sequence Data
Myeloid cells: ontogeny, maturation, markers, receptors
Peptides - pharmacology
Pertussis Toxin
Platelet Factor 4 - pharmacology
Polynuclears
Receptors, Immunologic - drug effects
Receptors, Interleukin-8A
Virulence Factors, Bordetella - pharmacology
title Activation of human basophils through the IL-8 receptor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T07%3A40%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Activation%20of%20human%20basophils%20through%20the%20IL-8%20receptor&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Krieger,%20M&rft.date=1992-10-15&rft.volume=149&rft.issue=8&rft.spage=2662&rft.epage=2667&rft.pages=2662-2667&rft.issn=0022-1767&rft.eissn=1550-6606&rft.coden=JOIMA3&rft_id=info:doi/10.4049/jimmunol.149.8.2662&rft_dat=%3Cproquest_cross%3E73237119%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16314324&rft_id=info:pmid/1383321&rfr_iscdi=true